ResearcherUniversity Hospital MagdeburgActive in the last 2 years

Michael Christoph Kreissl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5905-6015; OpenAlex author ID A5086684261. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair. Last author DOI 10.1007/s00259-025-07701-5 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Akram Al‐Ibraheem · 1 shared paper, 2026 · strength 0.29
- Paper Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranost… DOI 10.1007/s00259-025-07701-5 ↗
Johannes Notni · 1 shared paper, 2026 · strength 0.29
- Paper Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranost… DOI 10.1007/s00259-025-07701-5 ↗
Jan Wuestemann · 1 shared paper, 2026 · strength 0.29
- Paper Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranost… DOI 10.1007/s00259-025-07701-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.